Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae244 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Carolina Celades und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lymphoid Neoplasms Group, Josep Carreras Laukaemia Research Institute, Badalona, Spain. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Fundació Lluita Contra les Infeccions.
Abstract (Originalsprache)
Background
Drug–drug interactions between antiretroviral treatment (ART) and cytostatics may have a negative impact in the prognosis of people with HIV (PWH) and cancer.
Objective
The objective of this study is to evaluate the impact of the implementation of interdisciplinary management and the type of ART in PWH diagnosed with lymphoid neoplasms.
Methods
This is a multicentric, retrospective observational cohort study including PWH diagnosed with lymphoid neoplasm who started first-line chemotherapy between 2008 and 2020. Demographic, clinical and therapeutic variables were obtained from the electronic medical records and associated with 5-year progression-free survival (PFS) and overall survival (OS) using Cox proportional hazard models.
Results
A total of 118 individuals were included. Boosted ART was being used in 55 (46.6%) cases at the time of neoplasm diagnosis. The Infectious Diseases or the Pharmacy Department was consulted before starting chemotherapy in 79/118 (66.9%) cases. Interdisciplinary management resulted in fewer subjects taking boosted ART (17.7% versus 71.8%, P < 0.001) and more subjects using unboosted integrase strand transfer inhibitor–based ART (74.7% versus 7.7%, P < 0.001). The use of boosted ART with chemotherapy was associated with worse 5-year PFS (P = 0.003) and 5-year OS (P = 0.016). There was a trend towards better 5-year PFS and OS when interdisciplinary management was implemented, with significant differences for individuals receiving boosted ART at neoplasm diagnosis (P = 0.0246 and P = 0.0329, respectively).
Conclusions
Our findings underscore the significant impact of the type of ART on the prognosis of PWH undergoing chemotherapy. Encouraging collaborative management between oncologists, pharmacists and HIV teams for these patients enhances PFS and OS rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lymphoid Neoplasms Group, Josep Carreras Laukaemia Research Institute, Badalona, Spain.
- Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Pharmacy Department, Division of Medicines, Hospital Clinic-Fundació de recerca Clinic Barcelona-Institut de investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
- HIV Unit, Infectious Diseases Department, Hospital Clinic-Fundació de recerca Clinic Barcelona-Institut de investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
- CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
- Pharmacy Department, Division of Medicines, Hospital Clinic Barcelona, Barcelona, Spain.
ORCID-Profile: Sofia Sabato, Jose Molto
Förderung
- Fundació Lluita Contra les Infeccions
Zitieren
APA
Celades, C., Tuset, M., Ambrosioni, J., Calvo, J., Lizondo, T., Sabato, S., Guardia, A., Chapchap, E. C., Navarro, J. T., & Molto, J. (2024). Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae244
Vancouver
Celades C, Tuset M, Ambrosioni J, Calvo J, Lizondo T, Sabato S, et al. Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae244
BibTeX
@article{Celades2024,
author = {Celades, Carolina and Tuset, Montse and Ambrosioni, Juan and Calvo, Júlia and Lizondo, Thais and Sabato, Sofia and Guardia, Ares and Chapchap, Eduardo-Cerello and Navarro, Jose Tomas and Molto, Jose},
title = {Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae244}
}
EUVIMED